L1CAM and esophageal squamous cell carcinoma: To investigate whether Integrin β1 contributed to L1CAM mediated chemoresistance in ESCC, cisplatin was used to construct a chemotherapy model and followed down-regulation of Integrin β1 and L1CAM.